Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04825275 · ClinicalTrials.gov registry record · Early Phase 1
Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial
A Early Phase 1 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT04825275 is a Early Phase 1 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT04825275, a Early Phase 1 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This research is being done to find out if the study drug (posaconazole) can enter brain tumors at a high enough amount to stop the tumor cells from dividing. Posaconazole is a drug which doctors already use for fungal infections and is thought to be able to effect tumor cells. As treatments for this type of brain tumor are limited, it is hoped that the results of this study will help to determine if the study drug should be studied further as a possible treatment.
Interventions
- DRUG Posaconazole Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2024-11-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04825275
The ClinicalTrials.gov registry entry for NCT04825275 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Posaconazole Pill is the first listed.
NCT04825275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04825275 about?
NCT04825275 is a clinical study titled "Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial". This research is being done to find out if the study drug (posaconazole) can enter brain tumors at a high enough amount to stop the tumor cells from dividing. Posaconazole is a drug which doctors already use for fungal infections and is thought to be able to effect tumor cells. As treatments for thi...
What is the current status of trial NCT04825275?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2022-05-13. Estimated completion is 2024-11-06.
What interventions are being tested in trial NCT04825275?
The interventions under investigation include: Posaconazole Pill (DRUG).
Who is sponsoring clinical trial NCT04825275?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.